Early detection of amyloidopathy in Alzheimer’s mice by hyperspectral endoscopy

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 7, 2016, Pages 3231-3238

  More, Swati S ^a   Beach, James M ^b   Vince, Robert ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CytoViva Inc   (United States)

Author keywords

Alzheimer s; Endoscopy; Hyperspectral; Retina

Indexed keywords

ALZHEIMER DISEASE; AMYLOIDOPATHY; ARTICLE; COGNITION; DISEASE COURSE; ENDOSCOPY; FLUORESCENCE IMAGING; HYPERSPECTRAL ENDOSCOPY; IMAGE ANALYSIS; INFRARED SPECTROMETRY; LIGHT SCATTERING; MOUSE; NONHUMAN; OPTICAL DENSITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; AMYLOIDOSIS; ANIMAL; COMPLICATION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE MODEL; EARLY DIAGNOSIS; EYE FUNDUS; FOLLOW UP; PROCEDURES; REPRODUCIBILITY; RETINA; RETINAL DISEASES; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMALS; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; EARLY DIAGNOSIS; ENDOSCOPY; FOLLOW-UP STUDIES; FUNDUS OCULI; MICE; MICE, TRANSGENIC; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL DISEASES;

EID: 84975230084     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-17406     Document Type: Article

References (37)

1. Alzheimer's's Association. 2016 Alzheimer's's disease facts and figures. Available at: http://www.alz.org/facts/overview.asp. Accessed June 2, 2015.
2. Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimer's's disease. Folia Neuropathol. 2006;44:1-11.
3. Huang Y, Mucke L. Alzheimer's mechanisms and therapeutic strategies. Cell. 2012;148:1204-1222.
4. Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's's disease: a miniperspective. J Med Chem. 2010; 53:933-941.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's's disease in late onset families. Science. 1993;261:921-923.
6. Zekanowski C, Styczýnska M, Pepłónska B, et al. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's's disease in Poland. Exp Neurol. 2003;184:991-996.
7. Doecke JD, Laws SM, Faux NG, et al. Blood-based protein biomarkers for diagnosis of Alzheimer's disease. Arch Neurol. 2012;69:1318-1325.
8. Sunderland T, Linker G, Mirza N, et al. Decreased betaamyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease. JAMA. 2003;289:2094-2103.
9. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer's disease. Nat Rev Neurol. 2010;6:131-144.
10. Morris JC, Roe CM, Grant EA, et al. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer's disease. Arch Neurol. 2009;66: 1469-1475.
11. Thal LJ, Kantarci K, Reiman EM, et al. The role of biomarkers in clinical trials for Alzheimer's disease. Alzheimer's Dis Assoc Disord. 2006;20:6-15.
12. Anoop A, Singh PK, Jacob RS, Maji SK. CSF biomarkers for Alzheimer's's disease diagnosis. Int J Alzheimer'ss Dis. 2010; 2010:606802.
13. Frost S, Kanagasingam Y, Sohrabi H, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's's disease. Transl Psychiatry. 2013;3:e233.
14. Armstrong RA. Alzheimer's's disease and the eye. J Optom. 2009;2:103-111.
15. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's's disease. Invest Ophthalmol Vis Sci. 2007;48:2285-2289.
16. Tsai CS, Ritch R, Schwartz B, et al. Optic nerve head and nerve fiber layer in Alzheimer's's disease. Arch Ophthalmol. 1991; 109:199-204.
17. Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer's's disease. Brain Res. 1989; 501:364-372.
18. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging. 1996;17:385-395.
19. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's's disease. Neurosci Lett. 2007; 420:97-99.
20. Retinal amyloid fluorescence imaging predicts cerebral amyloid burden and Alzheimer's disease. Copenhagen, Denmark, July 12-17, 2014. Alzheimer's Association International Conference, 2014.
21. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, et al. Identification of amyloid plaques in retinas from Alzheimer's's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54:S204-S217.
22. More SS, Vince, R. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's's mouse retina well before onset of cognitive decline. ACS Chem Neurosci. 2015;6:306-315.
23. Jacques SL. Optical properties of biological tissues: a review. Phys Med Biol. 2013;58:R37-R61.
24. Paques M, Guyomard JL, Simonutti M, et al. Panretinal, highresolution color photography of the mouse fundus. Invest Ophthalmol Vis Sci. 2007;48:2769-2774.
25. Guyomard JL, Rosolen SG, Paques M, et al. A low-cost and simple imaging technique of the anterior and posterior segments: eye fundus, ciliary bodies, iridocorneal angle. Invest Ophthalmol Vis Sci. 2008;49:5168-5174.
26. Copland DA, Wertheim MS, Armitage JW, Nicholson LB, Raveney BJE, Dick AD. The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation. Invest Ophthalmol Vis Sci. 2008;49:5458-5465.
27. Chu CJ, Herrmann P, Carvalho LS, et al. Assessment and in vivo scoring of murine experimental autoimmune uveoretinitis using optical coherence tomography. PLoS One. 2013;8: e63002.
28. Schejter A, Tsur L, Farah N, Reutsky-Gefen I, Falick Y, Shoham S. Cellular resolution panretinal imaging of optogenetic probes using a simple funduscope. Trans Vis Sci Tech. 2012;1(2):4.
29. Focus Technologies, LLC. Maximum permissible exposure. Available at: http://www.focustechnologies.us/wp-content/ uploads/2013/12/Laser-safety-Wikipedia-Maximum-Exposure-Limits.pdf. Accessed May 31, 2016.
30. Prahl S. Optical absorption of hemoglobin. Available at: http:// omlc.ogi.edu/spectra/hemoglobin/index.html. Accessed May 2, 2016.
31. Quinten M, Stier J. Absorption of scattered light in colloidal systems of aggregated particles colloid. Polym Sci. 1995;273: 233-241.
32. Kalashnikov M, Choi W, Hunter M, Yu CC, Dasari RR, Feld MS. Assessing the contribution of cell body and intracellular organelles to the backward light scattering. Opt Express. 2012; 20:816-826.
33. Drexler W, Morgner U, Ghanta RK, Kartner FX, Schuman JS, Fujimoto JG. Ultrahigh-resolution ophthalmic optical coherence tomorgraphy. Nat Med. 2001;7:502-507.
34. Jentsch S, Schweitzer D, Schmidtke KU, et al. Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's's disease. Acta Ophthalmol. 2015;93:e241-e247.
35. Cooper GF, Robson JG. The yellow colour of the lens of man and other primates. J Physiol. 1969;203:411-417.
36. Mellerjo J. Light absorption and scatter in the human lens. Vision Res. 1971;11:124-141.
37. Pokorny J, Smith VC, Lutze M. Aging of the human lens. Appl Opt. 1987;26:1437-1440.